Preliminary results of an abiraterone acetate trial

John Neate, Chief Executive at The Prostate Cancer Charity, spoke to the Daily Telegraph, BBC Online and The Sun about the preliminary results of a trial of almost 800 men who took abiraterone acetate and lived almost four months longer than men given a placebo. Dr Sarah Cant, Head of Policy and Campaigns at the Charity, also joined Channel 4 News to discuss the results and the need for the drug to be made widely available for the men most at need.